Stock Traders Buy Large Volume of UnitedHealth Group Call Options (NYSE:UNH)

UnitedHealth Group Incorporated (NYSE:UNH) was the recipient of unusually large options trading on Friday. Traders purchased 145,490 call options on the stock. This represents an increase of approximately 120% compared to the typical daily volume of 66,007 call options.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Barclays maintained its Buy rating on UnitedHealth, signaling continued confidence in the company’s long-term outlook. Barclays Sticks to Their Buy Rating for UnitedHealth
• Positive Sentiment: Unusual options activity was bullish in tone, with investors purchasing substantially more UNH call options than the stock’s typical daily volume. This may indicate speculative expectations for a rebound, though options activity is not a guarantee of future performance.
• Positive Sentiment: UnitedHealth’s agreement with TPG to reshape Florida WellMed operations is intended to add local support and investment while helping Optum pursue faster growth and improved profitability. UnitedHealth Reshapes Florida WellMed Operations With TPG Deal
• Neutral Sentiment: UnitedHealthcare’s planned reduction of prior-authorization requirements could simplify care and lower administrative costs, but investors will watch whether the change improves member satisfaction without materially increasing medical expenses. The company plans to eliminate requirements for 30% of services by the end of 2026. UnitedHealth is Removing More Prior Authorizations
• Neutral Sentiment: UnitedHealth continues to be highlighted among profitable companies, while its dividend remains part of the investor appeal. However, these features have not prevented near-term selling pressure. 3 Profitable Stocks to Keep an Eye On
• Negative Sentiment: UNH declined even as the broader market advanced, suggesting company-specific concerns or profit-taking are weighing on sentiment. The stock remains below its 50-day moving average, although it is above its 200-day average. UnitedHealth Group Stock Drops Despite Market Gains

UnitedHealth Group Trading Down 2.4%

Shares of NYSE UNH opened at $378.83 on Friday. The stock has a market cap of $340.03 billion, a price-to-earnings ratio of 24.38, a PEG ratio of 1.46 and a beta of 0.61. The business has a 50 day simple moving average of $408.58 and a 200 day simple moving average of $367.71. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78. UnitedHealth Group has a 52 week low of $255.96 and a 52 week high of $461.62.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping the consensus estimate of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The company’s revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the previous year, the firm posted $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, research analysts predict that UnitedHealth Group will post 19.82 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be paid a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 59.72%.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.19% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. LFG Wealth Partners LLC increased its position in UnitedHealth Group by 3.3% in the 2nd quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate’s stock worth $355,000 after buying an additional 27 shares during the period. Synergy Financial Group LTD boosted its holdings in UnitedHealth Group by 3.1% in the 2nd quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate’s stock valued at $369,000 after purchasing an additional 27 shares during the period. Ares Financial Consulting LLC grew its position in UnitedHealth Group by 7.2% in the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock worth $174,000 after purchasing an additional 28 shares during the last quarter. Hudock Inc. raised its position in shares of UnitedHealth Group by 1.0% during the second quarter. Hudock Inc. now owns 2,844 shares of the healthcare conglomerate’s stock valued at $1,182,000 after buying an additional 28 shares during the last quarter. Finally, Rockland Trust Co. grew its position in UnitedHealth Group by 1.1% during the second quarter. Rockland Trust Co. now owns 2,589 shares of the healthcare conglomerate’s stock worth $1,076,000 after buying an additional 29 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on UNH shares. DA Davidson set a $512.00 price target on UnitedHealth Group in a report on Tuesday, July 21st. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, June 11th. HC Wainwright set a $492.00 price target on shares of UnitedHealth Group in a report on Wednesday, May 27th. JPMorgan Chase & Co. upped their price objective on shares of UnitedHealth Group from $466.00 to $516.00 and gave the company an “overweight” rating in a research note on Tuesday, July 21st. Finally, Wall Street Zen raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $456.56.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.

UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.